These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9775174)

  • 21. Images in clinical medicine. Acquired melanonychia.
    Ranta D; Bonmati C
    N Engl J Med; 2009 Sep; 361(12):1188. PubMed ID: 19759381
    [No Abstract]   [Full Text] [Related]  

  • 22. Nail pigmentation caused by hydroxyurea: report of 9 cases.
    Aste N; Fumo G; Contu F; Aste N; Biggio P
    J Am Acad Dermatol; 2002 Jul; 47(1):146-7. PubMed ID: 12077597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Longitudinal melanonychia and hydroxyurea].
    Pirard C; Michaux JL; Bourlond A
    Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyurea induced perimalleolar ulcers.
    Saravu K; Velappan P; Lakshmi N; Shastry BA; Thomas J
    J Korean Med Sci; 2006 Feb; 21(1):177-9. PubMed ID: 16479088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis.
    Karanth SS; Gupta A; Prabhu M
    Singapore Med J; 2014 Jan; 55(1):e7-8. PubMed ID: 24452985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How should patients with essential thrombocythemia be treated?].
    Ikeda Y
    Rinsho Ketsueki; 2001 Jun; 42(6):447-51. PubMed ID: 11505520
    [No Abstract]   [Full Text] [Related]  

  • 27. When and how to treat essential thrombocythemia.
    Barbui T; Finazzi G
    N Engl J Med; 2005 Jul; 353(1):85-6. PubMed ID: 16000360
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.
    Passamonti F; Cazzola M
    Haematologica; 2004 Nov; 89(11):1284. PubMed ID: 15531447
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
    Vélez A; García-Aranda JM; Moreno JC
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):243-4. PubMed ID: 10461646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transverse melanonychia and palmar hyperpigmentation secondary to hydroxyurea therapy.
    Schoenfeld J; Tulbert BH; Cusack CA
    Cutis; 2017 May; 99(5):E2-E4. PubMed ID: 28632807
    [No Abstract]   [Full Text] [Related]  

  • 31. A Violaceous, Photodistributed Cutaneous Eruption and Leg Ulcer in a Woman With Essential Thrombocytosis.
    Platto J; Alexander CE; Kurtzman DJB
    JAMA Dermatol; 2018 Jan; 154(1):95-96. PubMed ID: 28877306
    [No Abstract]   [Full Text] [Related]  

  • 32. Leg ulcers associated with long-term hydroxyurea therapy.
    Weinlich G; Schuler G; Greil R; Kofler H; Fritsch P
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):372-4. PubMed ID: 9703157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leg ulcer due to hydroxyurea. A case report].
    Gning SB; Debonne JM; Diagne-Guèye NM; Ndiaye B; Fall F; Mbaye PS
    Dakar Med; 2006; 51(2):89-91. PubMed ID: 17632983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia.
    Jabr FI; Shamseddine A; Taher A
    Am J Hematol; 2004 Dec; 77(4):374-6. PubMed ID: 15558807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Leg ulcer in a patient treated with hydroxyurea for polycythemia vera].
    Hanchi I; Zeglaoui F; Ezzine N; Daoud L; Karoui M; Fazaa B; Ridha Kamoun M
    Presse Med; 2006; 35(7-8):1174-6. PubMed ID: 16840894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty-Nail Transverse Melanonychia Induced by Hydroxyurea: Case Report and Review of the Literature.
    Osemwota O; Uhlemann J; Rubin A
    J Drugs Dermatol; 2017 Aug; 16(8):814-815. PubMed ID: 28809997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug-induced fever caused by hydroxyurea. Apropos of 3 new cases].
    Gallant C; Vial T; Allochon Y; Monier JM; Blanc M; Evreux JC
    Ann Med Interne (Paris); 1998 Mar; 149(2):59-61. PubMed ID: 11490525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
    Saraceno R; Teoli M; Chimenti S
    Clin Ther; 2008 Jul; 30(7):1324-9. PubMed ID: 18691992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
    Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
    N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acral keratoses and leucocytoclastic vasculitis occurring during treatment of essential thrombocythaemia with hydroxyurea.
    Worley B; Glassman SJ
    Clin Exp Dermatol; 2016 Mar; 41(2):166-9. PubMed ID: 26269121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.